Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald D Rao

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Expert Reviews in Molecular Medicine|August 19, 2010
Potential use of RNA interference in cancer therapyConnor Phalon, Donald D Rao, John Nemunaitis
Pharmaceutical Research|October 20, 2011
RNA interference and cancer therapyZhaohui Wang, Donald D Rao, Neil Senzer, et al.
Discovery Medicine|March 2, 2013
RNA interference and personalized cancer therapyDonald D Rao, Zhaohui Wang, Neil Senzer, et al.
Advanced Drug Delivery Reviews|April 25, 2009
siRNA vs. shRNA: similarities and differencesDonald D Rao, John S Vorhies, Neil Senzer, et al.
World Journal of Surgery|May 11, 2011
Personalized cancer approach: using RNA interference technologyJohn Nemunaitis, Donald D Rao, Shi-He Liu, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2012
Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical applicationDonald D Rao, Neil Senzer, Zhaohui Wang, et al.
Journal of Neuroscience Methods|April 9, 2005
Microarray analysis of fluoro-gold labeled rat dopamine neurons harvested by laser capture microdissectionFayi Yao, Fei Yu, Lijie Gong, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2016
Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous DeliveryZhaohui Wang, Christopher M Jay, Courtney Evans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2016
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's SarcomaDonald D Rao, Christopher Jay, Zhaohui Wang, et al.
Plos One|June 1, 2018
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplexDonald D Rao, Xiuquan Luo, Zhaohui Wang, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Expert Reviews in Molecular Medicine|August 19, 2010
Potential use of RNA interference in cancer therapyConnor Phalon, Donald D Rao, John Nemunaitis
Pharmaceutical Research|October 20, 2011
RNA interference and cancer therapyZhaohui Wang, Donald D Rao, Neil Senzer, et al.
Discovery Medicine|March 2, 2013
RNA interference and personalized cancer therapyDonald D Rao, Zhaohui Wang, Neil Senzer, et al.
Advanced Drug Delivery Reviews|April 25, 2009
siRNA vs. shRNA: similarities and differencesDonald D Rao, John S Vorhies, Neil Senzer, et al.
World Journal of Surgery|May 11, 2011
Personalized cancer approach: using RNA interference technologyJohn Nemunaitis, Donald D Rao, Shi-He Liu, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 3, 2012
Bifunctional short hairpin RNA (bi-shRNA): design and pathway to clinical applicationDonald D Rao, Neil Senzer, Zhaohui Wang, et al.
Journal of Neuroscience Methods|April 9, 2005
Microarray analysis of fluoro-gold labeled rat dopamine neurons harvested by laser capture microdissectionFayi Yao, Fei Yu, Lijie Gong, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 6, 2016
Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous DeliveryZhaohui Wang, Christopher M Jay, Courtney Evans, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 12, 2016
Preclinical Justification of pbi-shRNA EWS/FLI1 Lipoplex (LPX) Treatment for Ewing's SarcomaDonald D Rao, Christopher Jay, Zhaohui Wang, et al.
Plos One|June 1, 2018
KRAS mutant allele-specific expression knockdown in pancreatic cancer model with systemically delivered bi-shRNA KRAS lipoplexDonald D Rao, Xiuquan Luo, Zhaohui Wang, et al.
Pageof 2